Kolesnik OP, Kuzmenko VO. ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer. Pathologia [Internet]. 2020May25 [cited 2024Dec.23];(1). Available from: http://pat.zsmu.edu.ua/article/view/203639